Source:http://linkedlifedata.com/resource/pubmed/id/11722471
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
6
|
| pubmed:dateCreated |
2001-11-27
|
| pubmed:abstractText |
Defects of both sodium-hydrogen exchange (NHE) and sodium-lithium countertransport (SLC) have been described in subjects at increased risk of coronary heart disease (CHD). Sodium transport is linked to the regulation of cell volume, intracellular pH and cell growth, which may explain aspects of this association. However, impaired growth in early life is also linked to adult CHD, and 'programmed' alterations of cell behaviour are postulated to be responsible for this. In this study, therefore, we examined whether NHE or SLC in adults are predicted by anthropometric measures at birth, as well as being associated with insulin resistance syndrome (IRS) variables in adulthood. Red cell SLC was measured in 26 adults, and NHE in dermal fibroblasts from another 15 subjects characterized anthropometrically at birth. SLC activity correlated with LDL cholesterol, triglycerides and urate (r=0.42 - 0.49; 0.05 > P>0.01), but not birth anthropometry. NHE V(max) correlated with plasma insulin (r=0.80; P<0.001), but birth weight was unrelated to V(max), K(m) or Hill coefficient for H(i)(+). However, pH(i) correlated with birth weight (r=0.74; P=0.002), insulin sensitivity (r=0.52; P<0.05), fasting glucose (r=-0.52; P<0.05) 2 h insulin (r=0.51; P<0.05) 2 h glucose (r=-0.54; P<0.05). In conclusion, red cell SLC is related to IRS variables, but not with birth weight measures. In contrast, low intracellular pH(i) is related to both low birth weight and adult insulin resistance, suggesting it might be a 'programmed' cell phenotype, although this is not apparently explained by altered NHE kinetics.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Nov
|
| pubmed:issn |
0144-5979
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
21
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
640-7
|
| pubmed:dateRevised |
2006-11-15
|
| pubmed:meshHeading |
pubmed-meshheading:11722471-Anthropometry,
pubmed-meshheading:11722471-Antiporters,
pubmed-meshheading:11722471-Cardiovascular Diseases,
pubmed-meshheading:11722471-Erythrocytes,
pubmed-meshheading:11722471-Female,
pubmed-meshheading:11722471-Fetal Growth Retardation,
pubmed-meshheading:11722471-Fibroblasts,
pubmed-meshheading:11722471-Humans,
pubmed-meshheading:11722471-Hydrogen-Ion Concentration,
pubmed-meshheading:11722471-Insulin Resistance,
pubmed-meshheading:11722471-Intracellular Fluid,
pubmed-meshheading:11722471-Ion Exchange,
pubmed-meshheading:11722471-Male,
pubmed-meshheading:11722471-Middle Aged,
pubmed-meshheading:11722471-Phenotype,
pubmed-meshheading:11722471-Predictive Value of Tests,
pubmed-meshheading:11722471-Risk Factors,
pubmed-meshheading:11722471-Sodium-Hydrogen Antiporter
|
| pubmed:year |
2001
|
| pubmed:articleTitle |
Intracellular pH, intrauterine growth and the insulin resistance syndrome.
|
| pubmed:affiliation |
Department of Medicine, Clinical Sciences Centre, University Hospital, Aintree, Liverpool, UK.
|
| pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|